[
  {
    "ts": null,
    "headline": "J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?",
    "summary": "JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.",
    "url": "https://finnhub.io/api/news?id=9d6e05244b83880cade9cee8551356a10de2bfee1ac0ef7019ebf8205321e6f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750945200,
      "headline": "J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?",
      "id": 135560164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.",
      "url": "https://finnhub.io/api/news?id=9d6e05244b83880cade9cee8551356a10de2bfee1ac0ef7019ebf8205321e6f9"
    }
  },
  {
    "ts": null,
    "headline": "BSX vs. MDT: Which MedSurg Stock Is the Better Investment Now?",
    "summary": "As MedSurg demand rises, Boston Scientific and Medtronic compete for dominance. Which stock shows stronger growth momentum now?",
    "url": "https://finnhub.io/api/news?id=13403a92ef187c177efeeb8373305ad61cc76245f85f3d0909f52292f291d1cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750943760,
      "headline": "BSX vs. MDT: Which MedSurg Stock Is the Better Investment Now?",
      "id": 135560165,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "As MedSurg demand rises, Boston Scientific and Medtronic compete for dominance. Which stock shows stronger growth momentum now?",
      "url": "https://finnhub.io/api/news?id=13403a92ef187c177efeeb8373305ad61cc76245f85f3d0909f52292f291d1cb"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific exceeds analysts' estimates for seven straight quarters",
    "summary": "Boston Scientific has kicked off 2025 with impressive momentum, highlighted by strong financial results and strategic partnerships. The company's latest earnings report reveals substantial growth in...",
    "url": "https://finnhub.io/api/news?id=741dfa93b2b28e8d955a276ce44a64eecfce63f5b72adba098184a4bc4fc0957",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750914251,
      "headline": "Boston Scientific exceeds analysts' estimates for seven straight quarters",
      "id": 135543097,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Boston Scientific has kicked off 2025 with impressive momentum, highlighted by strong financial results and strategic partnerships. The company's latest earnings report reveals substantial growth in...",
      "url": "https://finnhub.io/api/news?id=741dfa93b2b28e8d955a276ce44a64eecfce63f5b72adba098184a4bc4fc0957"
    }
  }
]